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Expression of a Dominant Negative FGF
Receptor Inhibits Axonal Growth and FGF
Receptor Phosphorylation Stimulated by CAMs
Jane L. Saffell,* Emma J. Williams,*‡ Ivor J. Mason,† is illustrated by the fact that mutations in this CAM are
associated with severe neurological deficits, includingFrank S. Walsh,* and Patrick Doherty*
mental retardation and, in some instances, the loss of*Department of Experimental Pathology
corticospinal tracts (Wong et al., 1995).†Department of Developmental Neurobiology
It is clear that growth cones are required to integrateUnited Medical and Dental Schools
signals arising from a range of molecules in order toGuy’s Hospital
respond appropriately within a complex environment.London Bridge
The identification of receptor tyrosine kinases and phos-London SE1 9RT
phatases as modulators of axonal growth suggests thatUnited Kingdom
regulated tyrosine phosphorylation might be a funda-
mental signaling mechanism controlling growth cone
motility. This notion is strengthened by the fact thatSummary
neurite outgrowth stimulated by the above CAMs in-
volves activation of a second messenger cascade thatThe cell adhesion molecules (CAMs) NCAM, N-cad-
can be inhibited by a tyrosine kinase inhibitor (Williamsherin, and L1 are homophilic binding molecules that
et al., 1994a). Likewise, recent studies have shown thatstimulate axonal growth. We have postulated that the
integrin receptors on the tipsof extending filopodiacolo-above CAMs can stimulate this response by activating
calize with ‘hot-spots’ of tyrosine-phosphorylated pro-the fibroblast growth factor receptor (FGFR) in neu-
teins (Wu et al., 1996). The mechanisms whereby CAMsrons. In the present study, we demonstrate that activa-
and integrins might modulate tyrosine phosphorylationtion of NCAMand L1 can lead to phosphorylation of the
are incompletely understood.FGFR. Both this and the neurite outgrowth response
The FGFR family of tyrosine kinases is encoded bystimulated by all three of the above CAMs are lost
four genes, shows a considerable degree of diversitywhen a kinase-deleted, dominant negative form of
due to alternative splicing, and is expressed widely inFGFR1 is expressed in PC12 cells. In addition, we have
the developing nervous system (reviewed in Jaye et al.,generated transgenic mice that express the dominant
1992; Green et al., 1996). Activation of FGFRs is associ-negative FGFR under control of the neuron-specific
ated with increased survival and/or neurite outgrowthenolase (NSE) promoter. We show that cerebellar neu-
from a variety of primary neurons and the PC12 neuronalrons isolated from these mice have also lost their abil-
cell line (e.g., see Togari et al., 1985; Walicke, 1988;ity to respond to NCAM, N-cadherin, and L1. A peptide
Williams et al., 1994d). More recently, FGFR functioninhibitor of phospholipase C gamma (PLCg) that inhib-
has been shown to be required for the appropriate guid-its neurite outgrowth stimulated by FGF also inhibited
ance of retinal ganglion cell axons out of the developingneurite outgrowth stimulated by the CAMs. Thus, we
rat retina (Brittis et al., 1996) and for correct target cellconclude that activation of theFGFR is both necessary
recognition by retinal ganglion cells in the developingand sufficient to account for the ability of the above
retinal-tectal projection in Xenopus (McFarlane et al.,CAMs to stimulate axonal growth, and that PLCg is a
1996). Interestingly, both studies presented evidencekey downstream effector of this response.
suggesting the possibility of a non-FGF ligand being
required for correct axonal growth within the developing
retina. Based on a number of observations, including
Introduction antibody perturbation, we have suggested that NCAM,
N-cadherin, and L1 might stimulate neurite outgrowth
Axons obtain guidance information from a variety of by directly or indirectly activating a FGFR-PLCg cascade
sources, including soluble and cell- or extracellular ma- (Saffell et al., 1994; Williams et al., 1994a–c; Doherty et
trix-associated molecules as they navigate toward their al., 1995), but as yet there has been no direct evidence
target tissue during development. A large number of that CAMs can activate neuronal FGFRs.
ligands and receptors that promote and/or repel growth Receptor tyrosine kinases are activated by dimeriza-
cone advance have recently been identified. These in- tion or oligomerization, which leads to autophosphoryla-
clude the semaphorins (Messersmith et al., 1995), the tion on defined tyrosine residues in the cytoplasmic do-
netrins (Kennedy et al., 1994; Serafini et al., 1994; Cola- main of the receptor (reviewed in Schlessinger and
marino and Tessier-Lavigne, 1995), the Eph family of Ullrich, 1992). Expression of receptors that lack a tyro-
receptor tyrosine kinases (Drescher et al., 1995; Bram- sine kinase domain inhibits receptor function as a con-
billa and Klein, 1995), receptor tyrosine phosphatases sequence of the formation of dimers that lack kinase
(Desai et al., 1996; Krueger et al., 1996), neuronal inte- activity (Amaya et al., 1991; Ueno et al., 1992). In the
grins, and a number of cell adhesion molecules (CAMs), present study, we show that soluble chimeric forms of
including NCAM, N-cadherin, and L1 (reviewed in Rei- NCAM and L1 can stimulate tyrosine phosphorylation
chardt and Tomaselli, 1991; Doherty and Walsh, 1996). of FGFR1 in the PC12 neuronal cell line, and that this
The importance of L1 for normal human development response is ablated by expression of a kinase-deleted,
dominant negative form of the receptor (DN-FGFR). Fur-
thermore, we show that expression of the DN-FGFR in‡Present address: The Ludwig Institute, 91 Riding House Street,
London W1P 8BT, United Kingdom. both PC12 cells and primary neurons results in a loss
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of the neurite outgrowth response stimulated by NCAM, responsiveness to FGF2 (20ng/ml). In contrast to control
PC12 cells that stopped dividing and underwent neu-N-cadherin, and L1 in the absence of any effect on neu-
rite outgrowth stimulated by a wide variety of other ronal differentiation in response to FGF2 (Figure 2c),
cells expressing the dominant negative receptor failedagents. In addition, a peptide inhibitor of PLCg that in-
hibits neurite outgrowth stimulated by FGF (Hall et al., to differentiate and continued to divide (Figure 2f). In
contrast, NGF (50 ng/ml) inhibited the division and stim-1996) is shown to inhibit neurite outgrowth stimulated
by the above CAMs. Thus, we conclude that CAMs can ulated the morphological differentiation of both control
and transfected PC12 cells (Figures 2b and 2e). Theactivate the FGFR in neurons and that this is both neces-
sary and sufficient for the neurite outgrowth response. results clearly show that cells expressing the dominant
negative FGFR have lost responsiveness to FGF2 in the
absence of any effect on responsiveness to NGF.Results
Generation of PC12 Clones Expressing Loss of FGFR Function in PC12 Cells Is Associated
with a Loss of the CAM ResponseKinase-Deleted FGF Receptors
The rat PC12 cell line has been widely used as a model When PC12 cells are cultured on monolayers of parental
and CAM-transfected 3T3 cells, they respond to physio-for investigating the molecular mechanisms underlying
neuronal differentiation and axon outgrowth (Greene logical levels of NCAM, N-cadherin, and L1 by extending
longer neurites (Doherty et al, 1991b; Williams et al.,and Tischler, 1976). We transfected PC12 cells with a
kinase-deleted form of the mouse FGFR1 (DN-FGFR). 1992). To test for the requirement of the FGFR in this
response, we cultured PC12 cells that express dominantThis was tagged at the carboxyl terminus with the KT3
epitope tag from the SV40 large-T antigen (MacArthur negative FGFRs on monolayers of parental and CAM-
expressing 3T3 cells and compared their respon-and Walter, 1984). Three clones that stably express the
z95 kDa truncated receptor were selected from 30 siveness to that of control PC12 cells. After 44 hr, the
cultures were fixed and neurite lengths determined (Fig-clones screened by immunoblotting with an antibody
that recognizes the epitope tag on the transfected re- ure 3a). As expected, NCAM, N-cadherin, and L1 stimu-
lated neurite outgrowth from the control PC12 cells.ceptor (KT3 antibody, Figure 1a). Immunoblotting with
an antibody to the extracellular domain of the FGFR1, However, none of the CAMs stimulated neurite out-
growth from any of the three clones of PC12 cells thatwhich recognizes both the wild-type and dominant neg-
ative receptor, shows that the transgene does not alter express dominant negative FGFRs. This cannot be at-
tributed to an alteration in CAM expression level in theexpression of the endogenous receptor (z130 kDa, Fig-
ure 1a). Immunostaining of transfected PC12 cells (dif- PC12 cells, as immunoblotting failed to show any differ-
ence in expression levels of NCAM and L1 betweenferentiated with NGF) with the KT3 antibody shows that
the dominant negative receptor is expressed in a punc- control and transfected cells (data not shown). We have
also shown previously that a wide range of isolatedtate pattern on the PC12 cell bodies and neurites (Fig-
ure 1b). clones of PC12 cells that have been stably transfected
to express other gene products show no nonspecificThe relative number of FGFRs in transfected as com-
pared to parental PC12 cells was determined by cell reduction in CAM-dependent neurite outgrowth (Saffell
et al., 1994). In order to test whether the dominant nega-surface binding of 125I-labeled FGF2. Table 1 shows that
under conditions where there was a linear relationship tive FGFR was affecting growth in a nonspecific manner,
the control and transfected PC12 cells were cultured onbetween 125I-FGF2 binding and cell number, the trans-
fected cells bound between 10- and 27-fold more FGF2 3T3 monolayers in the presence of agents that promote
neurite outgrowth independently of CAMs: these werethan control PC12 cells. As the level of the endogenous
receptor did not change (see above), this increase is elevated levels of potassium, which mimics events
downstream of initial CAM binding by stimulating cal-clearly attributable to the expression of the dominant
negative receptor. To relate relative binding to an esti- cium influx (Saffell et al., 1992), or cholera toxin, which
increases cAMP levels and thereby activates proteinmate of the number of FGFRs per cell, cells from the
highest expressing clone were incubated with increas- kinase A. The results clearly show that expression of
the dominant negative FGFR does not impair respon-ing concentrations of 125I-FGF2 to reach saturated bind-
ing, and the data used for Scatchard analysis. The re- siveness to any of these agents (Figure 3b). Thus, ex-
pression of a dominant negative FGF receptor in PC12sults (Figure 1c) suggest that clone 2 has an estimated
3.09 3 105 receptors per cell, with an apparent Kd of cells inhibits neurite outgrowth stimulated by NCAM,
N-cadherin, and L1, but has no effect on neurite out-1.73 nM. The transfected cells clearly express levels of
dominant negative receptors that would be expected growth stimulated by potassium depolarisation or chol-
era toxin.to fully inhibit signaling through the wild-type receptor
(Ueno et al., 1992).
Neurons From Transgenic Mice Expressing
the DN-FGFR No Longer Respond to CAMsLoss of FGFR Function in Cells
Expressing DN-FGFRs NCAM, N-cadherin, and L1 also stimulate neurite out-
growth from a variety of primary neurons, including cere-PC12 cells in culture respond to NGF and FGF by assum-
ing the morphological and biochemical characteristics bellar granule cells and retinal ganglion cells, and these
responses can be inhibited by antibodies that bind toof sympathetic neurons (Greene and Tischler, 1976; To-
gari et al., 1985). To test for functional inactivation of the neuronal FGFR and by pharmacological agents that
inhibit the FGFR signal transduction cascade (DohertyFGFRs in the transfected PC12 cells, we tested their
Dominant Negative FGF Receptors and Axonal Growth
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Figure 1. Characterization of PC12 Cells
Transfected with DN-FGFR
(a) Immunoblot showing FGFR1 (left panel)
and KT3 (right panel) immunoreactivity in
control PC12 cells (WT) and DN-FGFR–
expressing clone 2 (DN). The anti-FGFR1
mAb (UBI) detects endogenous FGFR1 in WT
and DN cells (upper band) and DN-FGFR
(lower band) only in DN cells. As expected,
KT3 mAb only detects epitope-tagged DN-
FGFR in DN cells. For anti-FGFR1, 100 mg
crude membrane fraction were loaded per
lane, and for KT3 cells were directly lysed in
SDS-containing sample buffer and 50mg total
protein loaded per lane.
(b) KT3 immunostaining of PC12 cells ex-
pressing DN-FGFR. Control PC12 cells or
PC12 cells expressing KT3 epitope-tagged
DN-FGFR (clone 2) were cultured on colla-
gen-coated substratum in the presence of 50
ng/ml NGF. After 3 days, the cells were fixed,
permeablised, and immunostained with KT3.
PC12 cells expressing the DN-FGFR were im-
munoreactive (A) while control PC12 cells
were not (B).
(c) Scatchard analysis of 125I-FGF2 binding
to intact cells expressing DN-FGFR. 2 3 104
PC12 cells plated into individual wells of a
96-well plate were incubated for 2 hr at 48C
with 1 - 34 3 10214 moles 125I-FGF2 per well
in the presence and absence of excess unla-
beled FGF2 to determine nonspecificbinding.
Specific binding results were analysed by the
Scatchard method, as outlined in Experimen-
tal Procedures, to determine the number of
125I-FGF2–binding sites per cell (3.09 3 105)
and ligand dissociation constant (1.73 3
1029 M).
and Walsh 1996; Brittis et al., 1996). We have generated endogenous full-length FGF receptors would account
for the z170 kDa complex, and binding to the DN-FGFRtransgenic mice expressing DN-FGFR under control of
the neuron-specific enolase promoter, which targets transgene for the z100 kDa complex. Aswith PC12 cells,
expression of the full-length receptor is undiminishedtransgene expression to neurons at synaptogenesis
(Whitehead et al., 1982; Forss-Petter et al., 1990), and by expression of the transgene, which appears to be
approximately 10 times more abundant than the endog-tested early postnatal cerebellar neurons from wild-type
and heterozygous transgenic mice for their neurite out- enous receptor, as assessed by scanning of cross-link-
ing experiments such as Figure 4, or by comparing totalgrowth response to CAMs and various other agents.
Cross-linking of 125I-FGF2 to cultured cerebellar neurons 125I-FGF2 binding to wild-type and transgenic cerebellar
neurons (data not shown). To test their neuriteoutgrowthreveals an FGF-bound complex of z170 kDa in wild-
type and transgenic neurons and an additional lower response, we have isolated cerebellar neurons at post-
natal day 2–5 from wild-type and DN-FGFR–expressingmolecular weight complex (z100 kDa) in transgenic but
not wild-type neurons (Figure 4). 125I-FGF2 binding to transgenic mice and cultured them on monolayers of
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Table 1. Relative 125I-FGF2 Binding to Control and DN-FGFR- transgenic animals expressing the DN-FGFR (Figure 5b).
Expressing PC12 Cells The response to the soluble CAM-Fc chimeras could be
inhibited by treating neurons with antibodies to the same125I-FGF2 binding (moles/well)
CAM, and agents, including antibodies, that block vari-Control PC12 cells 1.07 6 0.27 3 10216
ous steps in the FGFR signal transduction cascadeClone 1 10.80 6 0.38 3 10216
(Doherty et al., 1995; Meiri et al., unpublished data).Clone 2 28.58 6 1.92 3 10216
Clone 3 17.70 6 0.82 3 10216 The signal transduction cascade underlying neurite
outgrowth stimulated by activation of the FGFR is wellTriplicate wells of a 96-well plate containing 2 3 104 control or DN-
characterized, and it can be activated at defined stepsFGFR-expressing PC12 cells were incubated for 2 hr on ice with
2.93 10214 moles/well 125I-FGF2 to determine relative 125I-FGF2 bind- by a variety of agents, including FGF, potassium depo-
ing. Nonspecific binding was assessed by coincubating in the pres- larization, and treatment with melittin or cholera toxin
ence of excess unlabeled FGF2 (5.6 3 10211 moles/well). The table (reviewed in Doherty and Walsh, 1996). Figure 5c shows
shows specific binding of 125I-FGF2 (moles/well) to control PC12 that neurons isolated from the transgenic animals and
cells and clones 1, 2, and 3 expressing the DN-FGFR in a single
wild-type neurons responded equally well to the latterexperiment, each figure being the mean from triplicate wells. Similar
three agents, but only wild-type neurons were able toresults were obtained in three further experiments.
respond to FGF2. Likewise, we found that NGF could
stimulate neurite outgrowth from both the transgenic
and wild-type neurons (Figure 5c), presumably by acti-control and CAM-expressing 3T3 cells. After 16 hr, the
vating the TrkA receptor tyrosine kinase expressed incultures were fixed, the neurons were stained for GAP43,
the developing cerebellum (Kioussi and Gruss, 1994).and mean neurite length was determined by measure-
Thus, we can conclude that expression of the dominantment of the longest neurite per cell. Neurons isolated
negative FGFR in transgenic neurons inhibits their re-from the wild-type mice responded to NCAM, N-cad-
sponse to FGF, NCAM, N-cadherin, and L1, but doesherin, and L1 by extending longer neurites (Figure 5a).
not in any way impair responsiveness to agents that actIn contrast, neurons isolated from the transgenic mice
downstream from the receptor activation step in thedid not respond to any of the three CAMs. In addition
FGFR signal transduction cascade, nor to agents thatto the transfection-based paradigm, where neurons re-
activate other receptor tyrosine kinases.spond to physiological levels of a CAM expressed in a
natural cellular environment, neurite outgrowth can be
stimulated by soluble CAM-Fc chimeras (Doherty et al., Activation of NCAM and L1 Can Lead
to Phosphorylation of the FGFR1995). In the present study, we found that L1-Fc and
NCAM-Fc chimeras stimulated neurite outgrowth from The above results show that FGFR function is required
for CAM-stimulated neurite outgrowth, and it has beenneurons isolated from wild-type animals, but not from
Figure 2. FGFR Function Is Compromised in PC12 Cells Expressing DN-FGFR
3 3 103 control (a–c) or DN-FGFR–expressing (d–f) PC12 cells (clone 2) were plated into individual wells of an eight-chamber slide coated
with poly-L-lysine and cultured in the absence (a and d) or presence of 50 ng/ml NGF (b and e) or 20 ng/ml FGF (c and f). After five days,
cells were fixed and stained with OX7 mAb to delineate PC12 cell morphology. Control PC12 cells differentiate in response to NGF and FGF,
while cells expresing DN-FGFR respond to NGF but keep dividing in the presence of FGF.
Dominant Negative FGF Receptors and Axonal Growth
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Figure 4. Transgenic Cerebellar Neurons Express DN-FGFR
125I-FGF2 was bound and cross-linked for 2 hr at 48C to wild-type
and transgenic cerebellar neurons cultured on poly-lysine–coated
tissue culture plates. Cells were lysed, proteins resolved by SDS-
PAGE, and the dried gel analyzedusing a Molecular Dynamics phos-
phorimager to visualize 125I-FGF2–bound complexes. A higher mo-
lecular weight complex (upper arrowhead) is common to wild-type
Figure 3. PC12 Cells Expressing DN-FGFR Do Not Respond (WT) and transgenic (TG) cerebellar neurons, while a smaller, more
to CAMs abundant complex (lower arrowhead) is only found in the transgenic
(a) Control- and DN-FGFR–expressing PC12 cells (clones 1–3) were lysate. 125I-FGF2 binding to endogenous full-length FGFR (upper)
cultured at low density on control 3T3 monolayers and monolayers and to DN-FGFR1 (lower) would account for these two complexes.
of 3T3 cells expressing NCAM, N-cadherin, or L1. After 44 hr, cocul-
tures were fixed and stained with OX7 for determination of mean
neurite length. The mean length of the longest neurite per cell was soluble CAMs or FGF2, as compared to control cells
measured for 150–200 PC12 cells in each population. The reponse (Figure 6a), or cells treated with NGF (data not shown).
is expressed as the percentage increase in mean neurite length on Furthermore, the CAMs and FGF did not stimulate phos-
CAM-expressing monolayers over basal outgrowth on control 3T3
phorylation of the FGFR in cells that express a dominantmonlayers. The results shown with control and DN-FGFR–
negative FGFR (Figure 6a). In addition, whereas NGFexpressing PC12 cells (clones 1, 2, and 3) were pooled from five
could stimulate tyrosine phosphorylation of Trk A inboth(control cells and clone 2), four (clone 1), or three (clone 3) indepen-
dent experiments. wild-type and DN-FGFR–expressing PC12 cells, NCAM-
(b) Expression of DN-FGFR does not inhibit neurite outgrowth in Fc, L1-Fc, and FGF2 had no effect on Trk A phosphoryla-
response to other agents. Control- and DN-FGFR–expressing PC12 tion (Figure 6b). Thus, we can conclude that FGF and
cells (clones 1, 2 and 3) were cultured on 3T3 monolayers in the
CAMs can specifically phosphorylate theFGFR1 in PC12presence of 40 mM KCl or 1 ng/ml cholera toxin (ChTx). Cocultures
cells and that this response is inhibited by the expres-were fixed and stained after 20 hr (ChTx) or 40 hr (KCl) for determina-
sion of the dominant negative FGFR.tion of mean neurite length (mm) 6 SEM as above.
A Peptide Inhibitor of PLCg Inhibits Neurite
Outgrowth Stimulated by the CAMsestablished that activation of the FGFR is sufficient to
account for the response (Williams et al., 1994c; Hall Phosphorylation of tyrosine 766 in the activated FGFR
creates a high affinity binding site for PLCg (reviewedet al., 1996). We therefore sought to determine if the
activation of neuronal CAMs, as induced by homophilic in Jaye et al., 1992; Schlessinger and Ullrich, 1992), and
a cell-permeable peptide containing this site (called thebinding, can induce phosphorylation of the FGFR, which
is a hallmark of receptor activation (Schlessinger and 766Y-P peptide) will inhibit both inositol phosphate accu-
mulation and neurite outgrowth stimulated by FGF2 (HallUllrich, 1992). We have previously shown that L1-Fc and
FGF2 can increase the level of tyrosine phosphorylation et al., 1996). This and other data (reviewed in Doherty
and Walsh, 1996) suggest that activation of PLCg isof a common, but unidentified set of neuronal substrates
in cultures of cerebellar neurons (Williams et al., 1994c). necessary and sufficient to account for the ability of the
activated FGFR to stimulate neurite outgrowth, at leastIn the present study, cultures of control or DN-FGFR–
expressing PC12 cells were incubated for 10 min with in cerebellar neurons. It follows that if CAMs are also
acting via this pathway, then the peptide should alsomedia containing FGF2 (100 ng/ml), or 10 mg/ml of solu-
ble NCAM-Fc or L1-Fc chimeras. Cells were then lysed inhibit CAM responses. Rat cerebellar neurons extend
neurites in response to L1-Fc immobilized to a tissueand incubated with an antibody that binds tyrosine-
phosphorylated proteins. Immunoprecipitates were re- culture substratum (Williams et al., 1995b). The data in
Figure 7a show that pretreatment of rat neurons withsolved by SDS–PAGE and immunoblotted with an anti-
body recognizing FGFR1. The results show an increase 766Y-P peptide inhibits the L1 response in a dose-depen-
dent manner, with 10 mg/ml peptide giving near maximalin the phosphorylation of the FGFR in cells treated with
Neuron
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Figure 6. NCAM and L1 Phosphorylation of FGFR1
(a) Cultures of control (WT) or DN-FGFR–expressing (DN) PC12 cells,
serum-starved for 2 hr and incubated for 10 min in the presence of
10 mg/ml NCAM-Fc, 10 mg/ml L1-Fc, or 100 ng/ml FGF2 were lysed
and immunopecipitated with an antiphosphotyrosine antibody. Fc
chimeras containing the first three Ig domains of each CAM, which
are as effective as full-length CAM-Fc chimeras in neurite outgrowth
assays, were used in this set of experiments. Immunoprecipitates
were resolved by SDS-PAGE and nitrocellulose replicas immuno-
probed with an anti-FGFR1 mAb (UBI). Tyrosine-phosphorylated
FGFR1 precipitates from cultures of PC12 cells (WT) treated with
NCAM-Fc (2), L1-Fc (3), or FGF2 (4), but not from the untreated
control culture (1), or from DN-FGFR–expressing cells (DN) treated
with CAMs (2 and 3) or FGF (4).
(b) Untreated control cultures of wild-type (WT) PC12 cells (1) and
cultures treated with 10 mg/ml NCAM-Fc (2), 10 mg/ml L1-Fc (3), 100
ng/ml FGF2 (4), or 100 ng/ml NGF (5), and DN-FGFR–expressing
PC12 cells (DN), untreated (1) or treated with 100 ng/ml NGF(2), were
lysed and immunoprecipited with an anti-Trk receptor antibody.
Immunoprecipitates were resolved by SDS-PAGE and nitrocellulose
replicas immunoprobed with an antiphosphotyrosine antibody. Ty-
rosine-phosphorylated Trk A receptor precipitates only from WT
and DN-FGFR–expressing cells treated with NGF.
Figure 5. Cerebellar Neurons Expressing DN-FGFR Respond to a
Variety of Agents but Not to CAMs or FGF
signal transduction cascade (Hall et al., 1996). Likewise,(a) PND 2–5 wild-type (WT) or transgenic (TG) neurons were cultured
the peptide does not inhibit neurite outgrowth stimu-at low density on control 3T3 monolayers and monolayers of 3T3
cells expressing NCAM, N-cadherin, or L1. Cocultures were fixed lated by NGF (Figure 7b). Thus, we can conclude that
after 16 hr and stained with an anti-GAP43 antibody for measure- its effects on neurite outgrowth are relatively specific
ment of neurites. The mean length of the longest neurite per cell and are not due to toxicity. Since the response to NCAM,
was measured for 150–200 neurons in each population. The results
N-cadherin, and L1 is disrupted by the dominant nega-show the mean neurite length (mm) 6 SEM pooled from six indepen-
tive FGFR and the peptide inhibitor of PLCg, we woulddent experiments.
suggest that activation of the FGFR-PLCg cascade is(b) Wild-type and transgenic neurons were cultured for 16 hr on 3T3
monolayers in the presence of 10 mg/ml L1-Fc or NCAM-Fc before required for neurite outgrowth stimulated by the above
being fixed and stained as for (a). CAMs and FGF2.
(c) Neurons were cultured as for (a) on 3T3 monolayers in the pres-
ence of 40 mM KCl, 1 ng/ml cholera toxin (ChTx), 0.1 mM Melittin
Discussion(Mel), 50 ng/ml NGF, or 50 ng/ml FGF2 for 16 hr before fixing and
staining as above. The results show the mean neurite length (mm) 6
SEM pooled from three (KCl, cholera toxin, melittin, NGF) or four For many years, the putative axon growth and guidance
(FGF2) independent experiments. properties of CAMs were attributed solely to their ability
to mediate or modulate adhesive interactions between
growth cones and the substrates that they encounter.
However, it has recently become clear that some CAMsinhibition. In addition, the peptide inhibits neurite out-
growth stimulated by physiological levels of NCAM, are also able to promote neurite outgrowth by activating
a second messenger cascade in neurons (reviewed inN-cadherin, and L1 expressed in 3T3 cells (Figure 7b).
The peptide does not inhibit neurite outgrowth stimu- Doherty and Walsh, 1994). In this context, recent experi-
ments have led to the hypothesis that NCAM, N-cad-lated by arachidonic acid,which has been demonstrated
to be generated downstream from PLCg in the FGFR herin, and L1 can stimulate axonal growth by activating
Dominant Negative FGF Receptors and Axonal Growth
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signaling pathway. The use of dominant negative recep-
tor tyrosine kinases has become established as a critical
method for determining the requirement of a particular
receptor in a signaling cascade, and with this in mind,
we made a panel of PC12 cells that express a kinase-
deleted FGFR.
In an initial series of experiments, we characterized
the transfected PC12 cells and demonstrated that they
had lost responsiveness to FGF2. We next took advan-
tage of the fact that PC12 cells are an established model
for studying CAM-stimulatedneurite outgrowth (Doherty
et al., 1991b; Saffell et al., 1992, 1994), and tested the
three independent clones of PC12 that had lost FGFR
function for their ability to respond to NCAM, N-cad-
herin, or L1. In contrast to control PC12 cells, which
extended longer neurites in response to all three CAMs,
cells expressing the dominant negative receptor failed
to respond to any of the CAMs. The possibility of non-
specific effects of the transgene on neurite outgrowth
can be excluded, as the transfected PC12 cells were
able to differentiate normally in response to NGF, potas-
sium depolarization, and cholera toxin. Thus, expression
of dominant negative FGFRs in PC12 cells is associated
with a clear phenotype, namely, a lossof responsiveness
to FGF2, as expected, but also a loss of responsiveness
to the above three CAMs.
In relation to CAM-stimulated neurite outgrowth, there
is a complete concurrence among observations made
with PC12 cells cultured over transfected 3T3 mono-Figure 7. The 766Tyr-P Peptide Inhibits CAM-Stimulated Neurite Out-
layers and observations made with cerebellar neuronsgrowth
(e.g., see Saffell et al., 1994). Likewise, where tested,(a) Dissociated cerebellar neurons from PND1 rats were cultured on
any agent that inhibits CAM-stimulated neurite out-tissue culture plastic coated with poly-lysine alone (PL) or poly-
growth from cerebellar granule cells also inhibits CAM-lysine followed by L1-Fc (PL1L1-Fc, see Experimental Procedures).
The neurons were pretreated for 60 min with 0, 1, 10, or 100 mg/ stimulated axonal growth from embryonic rat DRG neu-
ml 766Y-P peptide before being washed and plated onto the two rons (Harper etal., 1994) and retinal ganglion cells (Brittis
substrates. After 16 hr, cultures were fixed and stained for measure- et al., 1996). We thus believe that axonal growth stimu-
ment of neurite length (see legend to Figure 5). The results show
lated by the above CAMs involves activation of a path-the mean length of the longest neurite percell (mm) 6 SEM measured
way that is common to most, if not all, neurons. To testfor 150–200 neurons in each population.
this further, we have generated transgenic mice that(b) PND3 mouse cerebellar neurons were cultured on 3T3 mono-
express the dominant negative FGFR under the controllayers in the absence or presence of 100 ng/ml NGF or FGF, and
on monolayers of 3T3 cells expressing NCAM, N-cadherin, or L1, of the NSE promoter. This promoter comes on at or after
all in the absence and presence of 10 mg/ml 766Y-P peptide. After synaptogenesis (Schmechel et al., 1980; Whitehead et
16 hr, cultures were fixed and stained for measurement of neurite al., 1982), and this probably explains why we do not see
length. The results are expressed as the percentage inhibition by
any obvious developmental phenotype in the transgenic766Y-P peptide of the neurite-length increase stimulated by NCAM,
animals. However, in preliminary experiments, we haveN-cadherin, L1, NGF, and FGF2.
found impaired regeneration following lesion in adult
animals (authors’ unpublished data). Cerebellar neurons
taken from the transgenic mice and placed in culture
neuronal FGFRs (Saffell et al., 1994; Williams et al., clearly express the dominant negative FGFR, as shown
1994c, 1994d). If this hypothesis were substantiated, it by 125I-FGF2 cross-linking and confirmed by functional
would suggest that regulated tyrosine phosphorylation studies. These neurons behave identically to the trans-
might be a common mechanism underlying the ability fected PC12 cells in that they grow normally on 3T3
of a wide range of molecules to promote and/or inhibit monolayers, a response likely to be mediated by inte-
axonal growth (see Introduction). grins (Williams et al., 1994a), but fail to respond to FGF2,
Although antibody perturbation experiments lend or NCAM, N-cadherin, and L1 expressed in 3T3 cells.
support to the hypothesis that FGFR function is required Likewise, the soluble L1- and NCAM-Fc chimeras also
for CAM-stimulated neuriteoutgrowth (e.g., see Williams fail to stimulate neurite outgrowth from these cells, in
et al., 1994c), such experiments can be challenged on contrast to their wild-type counterparts. However, the
the basis that the antibodies might not be specific or, same neurons respond normally to NGF and to three
perhaps more critically, that the binding of antibodies agents that activate downstream steps in the FGFR sig-
might trigger a direct response in the neuron which naling cascade, and thus again we can conclude that
through ‘cross-talk’ inhibits a distinct pathway activated they exhibit a highly specific phenotype in that they have
by the CAMs. Thus, we have adopted an alternative lost their ability to respond to CAMs, but not to a range
of other agents.strategy to test the requirement of the FGFR in the CAM
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We have previously shown that antibodies and pep- number of observations support the latter possibility.
First, direct activation of the signaling cascade withtides that inhibit FGFR function also inhibit neurite out-
growth stimulated by NCAM, N-cadherin, and L1 (Wil- FGF2, or agents that have been postulated to activate
downstream steps, including arachidonic acid, melittinliams et al., 1994c). Likewise, desensitization of the
FGFR signaling cascade with high levels of FGF2 results (which stimulates arachidonic acid production via acti-
vation of phospholipase A2), potassium depolarization,in a cross-desensitization of the above CAM responses
(Williams et al., 1995b). Also, a large number of pharma- and cholera toxin, all fully mimic the CAM response in
a nonadditive manner (Saffell et al., 1992, Williams etcological agents (the erbstatin analogue tyrosine kinase
inhibitor, a DAG lipase inhibitor, agents that block cal- al., 1992, 1994b, 1995b). Thus, activation of the FGFR
can fully account for the CAM responses. Second, wecium influx into neurons, and a Ca21/calmodulin kinase
inhibitor) block neurite outgrowth stimulated by FGF2 now have direct evidence that NCAM and L1 can phos-
phorylate the FGFR, which is a hallmark of receptorand the above CAMs (Williams et al., 1994d, 1995a; Hall
et al., 1996). We add to this list in the present study by activation. We have previously shown that the L1-Fc
chimera and FGF2 can stimulate tyrosine phosphoryla-showing that an FGFR-derived peptide that binds to the
SH2 domain of PLCg and inhibits inositol phosphate tion of a common set of substrates incultures of cerebel-
lar neurons, and that both responses are inhibited byaccumulation and neurite outgrowth stimulated by FGF2
also inhibits neurite outgrowth stimulated by NCAM, antibodies that block FGFR function (Williams et al.,
1994c). In the present study, we have shown phosphory-N-cadherin, and L1. This inhibitor has no effect on neu-
rite outgrowth stimulated by NGF, and this might reflect lation of the FGFR1 in cultures of PC12 cells treated
with soluble NCAM- and L1-Fc chimeras. This responsean inability to inhibit the activation of PLCg by NGF, or,
alternatively, suggest that the response stimulated by was, as expected, not found in PC12 cells expressing
the dominant negative FGFR. As a specificity control,NGF does not require activation of PLCg. The PLCg
peptide also inhibited neurite outgrowth stimulated by we demonstrated that CAMs and FGF did not phos-
phorylate Trk receptors, which were, however, phos-the L1-Fc chimera coated to a tissue culture substrate,
and we have shown that this response can also be inhib- phorylated by NGF in both wild-type and DN-FGFR–
expressing cells.ited by a range of agents that block FGFR function,
including antibodies to the receptor, the DAG lipase The final important consideration therefore becomes
how CAMs might activate the FGFR in neurons. Oneinhibitor, an intracellular calcium chelator and a Ca21/
calmodulin kinase inhibitor (Williams et al., 1995b). possibility is that the homophilic binding of CAMs could
alter the expression of FGFs, or in some way potentiateTaken together, the results with the various inhibitors,
and a number of mimetics, suggest that the neurite out- signaling by low levels of FGF present in the culture. An
alternative possibility is that CAMs themselves might begrowth response stimulated by the above CAMs in-
volves a cascade that includes activation of the FGFR, ligands for the FGFR, and that, following homophilic
binding and possibly clustering, a cis interaction be-activation of PLCg to generate DAG, conversion of DAG
to arachidonic acid by DAG lipase, and an arachidonic tween the CAM and the FGFR might lead to recruitment
of the FGFR into a complex in a manner that allows foracid-dependent stimulation of calcium influx into neu-
rons (for review, see Doherty and Walsh, 1996). Further- receptor activation. At present, there is no unequivocal
piece of data that can distinguish between these mod-more, they demonstrate that this pathway is important
for the growth response stimulated by physiological lev- els. However, based on a number of observations, we
favor the latter possibility. For example, the phosphory-els of transfected NCAM, N-cadherin, and L1 expressed
in cells, as well as the response stimulated by soluble lation of neuronal substrates by soluble L1-Fc occurs
over a rapid time course similar to that induced by FGFNCAM and L1-Fc chimeras or the L1-Fc chimera affinity
captured on to a tissue culture substrate. However, we (Williams et al., 1994c), and NCAM- and L1-Fc will phos-
phorylate FGFR1 in PC12 cells within minutes (thishave noted that in some circumstances (relatively high
levels of coated CAM) the growth over the substrate- study). This rapid response to CAMs would seem to
preclude the possibility that their effect depends on abound L1-Fc chimera is not inhibited by some of the
agents that block the FGFR signaling cascade (dis- CAM-induced increase in FGF synthesis. The possibility
that they enhance signaling by low levels of endogenouscussed in Doherty and Walsh, 1996). It is possible that
higher levels of the coated CAM might recruit additional FGF is also unlikely as, based on perturbation experi-
ments with antibodies and pharmacological agents, wesignaling cascades or even promote growth through
mechanisms related to the adhesive rather than signal- find no evidence for functional levels of FGF in our cul-
tures. Also, antibodies to FGF and peptides that inhibiting function of L1. In this context, it is far from clear
whether high levels of immobile CAM on a tissue culture FGF function do not block the neurite outgrowth re-
sponse stimulated by the CAMs. The alternative possi-substrate approximate to a physiologically relevant
model of axonal growth. It is, however, clear that the bility that CAMs themselves might be able to directly
interact with FGFRs is supported by the fact that theCAM component of growth over astrocyte monolayers,
which can be considered to be a more physiologically FGFR contains two CAM homology domains that show
evolutionary conservation of motifs established to playrelevant model than CAM-transfected fibroblasts, is also
inhibited by the agents that block the FGFR-PLCg sig- a role in CAM binding (reviewed in Doherty and Walsh,
1996).naling cascade (Williams et al., 1995b).
The results with the dominant negative FGFRs can Our work establishes that soluble CAMs can mimic
FGF-stimulated neurite outgrowth. However, we do notbe interpreted in one of two ways. The FGFR could
conceivably be upstream or downstream of the CAM- believe that this extends toevery aspect of FGF function,
for a number of reasons. First, some functions of FGFbinding step in a pathway leading to axonal growth. A
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with Msc I to truncate the receptor at amino acid 418, and insertionare apparently independent of the high affinity FGFR
of oligodeoxynucleotides encoding an epitope tag anda stop codon.activation, and might involve direct effects of FGF in the
The epitope tag, PPEPET, corresponds to the last six amino acidsnucleus (Imamura et al., 1990). Second, there are a large
of SV40 large T antigen, which is recognizedby themAb KT3 (MacAr-
number of FGFRs (by virtue of the fact that there are thur and Walter, 1984). The epitope tag, stop codon, and restriction
four genes and many splice variants), and they do not sites to aid subcloning were created by annealing and ligating
the following oligodeoxynecleotides to Msc 1–digested FGFR1:all signal in an identical manner (Vainikka et al., 1994).
CCCCGCCCGAGCCAGAGACTTAATCTAGAAGCTT and AATTAAGThird, if CAMs directly activate FGFRs, these might be in
CTTCTAGATTAAGTCTCTGGCTCGGGCGGGG. The N-terminus ofa different cellular compartment (e.g., axon and growth
the cDNA was modified by introducing an idealized Kozak sequencecone and not cell body) from the receptors activated by
to aid initiation of translation. For PC12 cell transfection, the domi-
FGFs. Finally, CAMs and FGFs could conceivably activate nant negative mutant was ligated to the expression vector pRcCMV
the receptor in a fundamentally different manner. (Invitrogen, USA) with expression directed by the CMV promoter
and G418 resistance conferred by a neomycin gene on the sameBased on experiments with “knockout” mice, it has
plasmid. CsCl2 purified plasmid (10 mg) was linearized by digestionbeen suggested that pp60c-src is a component of the
with Pvu1 and introduced into exponentially growing PC12 cells byL1 signaling pathway leading to neurite outgrowth,
electroporation, as described previously (Saffell et al., 1994). Thewhereas pp59fyn is a component of the NCAM pathway
transfected cells were cultured in SATO media containing 500 mg/ml
(Beggs et al., 1994; Ignelzi et al., 1994). It is not clear G418. Clones were isolated and expanded as previously described
how these results relate to the hypothesis that these (Saffell etal., 1994). PC12 cell lines expressing DN-FGFR were identi-
fied by probing immunoblots of whole cell extracts with KT3. TheCAMs stimulate neurite outgrowth by activating neu-
control (mock-transfected) PC12 cells used in the present studyronal FGFRs. It is possible that these nonreceptor tyro-
were transfected with the parental plasmid, expressed G418 resis-sine kinases function upstream from the CAM-binding
tance, and had a similar culture history to those expressing the DN-step in an “inside-out” manner by regulating the ability
FGFR. To generate transgenic mice, the DN-FGFR cassette was
of CAMs to act as ligands, as has been described for inserted into the pNSE-Ex4 vector (gift of Dr. Sonja Forss-Petter,
integrin receptors (reviewed in Ginsberg et al., 1992). Scripps Research Institute) downstream from the neuron-specific
enolase promoter (Forss-Petter et al., 1990; Mucke et al., 1994). TheAlternatively, these nonreceptor tyrosine kinases might
6.2 Kb NSE promoter-DN-FGFR fragment was released by Sal I andbe components of the FGFR signal transduction cas-
injected into C57/Black6 3 CBA(F2) fertilized oocytes, and two-cellcade, or represent an additional pathway whereby
embryos were implanted into pseudopregnant recipients. Trans-CAMs can stimulate neurite outgrowth. These questions
genic progeny were identified by RT–PCR and immunoblotting with
will be resolved in part by determining if the CAMs and KT3. The highest expressing of 10 founder males was bred to homo-
FGFs can activate these kinases and whether this is zygosity and used to father heterozygous transgene–expressing lit-
ters, which were used for the in vitro studies. Cell surface expressionsufficient to then account for the growth response.
of the DN-FGFR transgene in these heterozygotes was confirmedBy showing that FGFR function is required for CAM
by 125I-FGF2 binding analysis to cultured cerebellar neurons.responses and that CAMs can activate the FGFR, this
study provides a fully comprehensive test of the hypoth-
Cell Cultureesis that activation of neuronal FGFRs by NCAM,
Parental 3T3 cells and 3T3 cells expressing human l40 kDa NCAM,
N-cadherin, and L1 is the key step in a signaling pathway chick N-cadherin, or human L1 were routinely cultured on tissue
underlying the neurite outgrowth response stimulated culture plastic in DMEM supplemented with 10% FCS. PC12 cells
by these CAMs.One potential site of interaction between were cultured in SATO medium (Doherty et al., 1990), supplemented
with 2% FCS and 500 mg/ml G418. All cells were grown at 378C inCAMs and the FGFR is in the developing retina, where
8% CO2. For establishment of cocultures, 3T3 cells were seeded atsimilar errors in pathfinding are induced by antibodies
a density of 8 3 104 per chamber of an eight-chamber slide (Lab-that block the function of NCAM, L1, and the FGFR, and
Tek, Naperville, IL) previously coated sequentially with poly-L-lysine
by pharmacological agents that inhibit the FGFR signal and fibronectin (Doherty et al., 1990), and allowed to form confluent
transduction cascade (Brittis et al., 1996). Likewise, the monolayers overnight. PC12 cells were introduced onto the mono-
expression of a dominant negative FGFR in Xenopus layers at a density of 1.5 3 103 cells per chamber and were main-
tained for 40–44 hr in SATO medium containing 2% FCS beforeretinal ganglion cells results in a substantial reduction
being fixed with paraformaldehyde for 35 min for staining as below.in the number of retinal ganglion cell axons leaving the
Cerebellar neurons, which were isolated from postnatal day (PND)retina, and the fact that a similar effect is observed with
2–5 mice as previously described (Doherty et al., 1991a), were intro-
a mutant receptor that does not inhibit FGF signaling duced onto monolayers at a density of 3 3 103 cells per chamber
led the authors to suggest that activation of FGFRs by and maintained for 16 hr in SATO medium containing 2% FCS before
a non-FGF ligand might be important for axon initiation being fixed and stained. Where PC12 cells and cerebellar neurons
were cultured in the presence of other agents such as KCl, melittinand extension within the eye (McFarlane et al., 1996).
(Sigma), NGF (Promega), cholera toxin (Sigma), 766Y-P peptide, etc.,Finally, our results suggest that ‘cross-talk’ between
these were added 2 hr after the neuronal cells to rule out theiradhesion and tyrosine phosphorylation can play a de-
possible interference with cell attachment. In one set of experi-
termining role in biological processes, and underscore ments, rat cerebellar neurons were pretreated for 60 min with the
the importance of regulated tyrosine phosphorylation 766Y-P peptide as previously described (Hall et al., 1996) before being
as a fundamental signaling process controlling growth cultured on tissue culture substrata coated with L1-Fc chimera (see
below).cone behavior.
Experimental Procedures Immunostaining
Fixed cocultures were immunostained for determination of neurite
length. Nonspecific protein-binding sites were blocked with 10%Generation of PC12 Cells and Transgenic Mice Expressing
a Dominant Negative Form of FGFR1 FCS, followed by, for PC12 cells, sequential incubation with the OX7
mAb, which recognizes Thy-1 and biotinylated antimouse immuno-A dominant negative form of the mouse FGFR1 (DN-FGFR) was
created from a full-length cDNA clone encoding the three-immuno- globulin, or for cerebellar neurons, anti–GAP-43 antiserum and bio-
tinylated antirabbit immunoglobulin, followed by Texas red–globulin domain form of the FGFR1 (Safran et al., 1990). The domi-
nant negative kinase domain–deleted form was created by digesting conjugated streptavidin (Amersham, diluted 1:500 in PBS/0.5 mg/
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ml BSA). To determine the presence and distribution of epitope- 125I-FGF2 Binding to Intact PC12 Cells
Control and DN-FGFR–expressing PC12 cells were plated at a den-tagged DN-FGFR in transfected PC12 cells, they were immuno-
stained using KT3. PC12 cells wereplated on collagen-coated eight- sity of 2 3 104 cells per well of a 96-well plate previously coated
with poly-lysine. After 24 hr, the culture medium was removed fromchamber tissue culture slides (LabTek) at a density of 1 3 104 cells
per well in the presence of 50 ng/ml NGF. After 3 days, cells were each well and the cells washed once with ice-cold binding buffer
(DMEM containing 20 mM HEPES, 1 mg/ml BSA, and 20 mg/ml hepa-fixed in 2% paraformaldehyde for 20 min and then permeablized
for 10 min in 1% (v/v) TritonX-100 in PBS. Nonspecific binding sites rin). To compare the number of FGF-binding sites on control PC12
cells with sites on clones 1, 2, and 3 expressing the DN-FGFR,were blocked with 10% FCS in PBS/0.5 mg/ml BSA for 1 hr. KT3
primary antibody (1:5 dilution of tissue culture supernatant), biotiny- triplicate wells containing each cell line were incubated with 2.9 3
10214 moles/well 125I-FGF2 for 2 hr on ice. Under these conditions,lated antimouse secondary antibody (Amersham), and Texas red–
conjugated streptavidin (Amersham) were all added sequentially in there was a linear relationship between 125I-FGF2 binding and the
number of available sites. Nonspecific binding was assessed byPBS/0.5 mg/ml BSA containing 0.2% (v/v) TritonX-100 for 1 hr at
room temperature. incubating cells in triplicate wells with unlabelled FGF2 (5.6 3 10211
moles/well) in addition to the labeled FGF2. After the 2-hr incubation
period, the medium was removed and the cells washed three times
Immunoblotting with ice-cold DMEM containing 20 mM HEPES, lysed in 200 mM
KT3: Control and DN-FGF–expressing PC12 cells growing on poly- NaOH, and transferred to tubes containing scintillation fluid (Aqua-
L-lysine–coated 6 cm tissue culture plates were lysed in ice-cold sol, Packard). Samples were counted in a Beckman scintillation
SDS-containing sample buffer. Protein extracts (50 mg) were re- counter (LS 6000 IC).
solved by electrophoresis on 7.5% polyacrylamide minigels and
transferred to nitrocellulose membranes. The nitrocellulose replicas Scatchard Analysis
were incubated for 2 hr at room temperature with 4% casein in PBS Triplicate wells containing 2 3 104 DN-FGFR–expressing PC12 cells
to block nonspecific protein binding sites, followed by sequential (clone 2) were incubated on ice for 2 hr with a range of six concentra-
incubation for 1 hr each with KT3 tissue culture supernatant diluted tions (1 - 34 3 10214 moles/well) of 125I-FGF2. For each concentration,
1:2 in 1% casein in PBS and peroxidase conjugated goat antimouse nonspecific binding was determined by coincubating with excess
immunoglobulin (Biorad, diluted 1:3000 in 1% casein in PBS). After unlabeled FGF2 (5.6 3 10211 moles/well). For the Scatchard plot,
washing, immunoreactive bands were visualised using an ECL de- bound/free 125I-FGF2 was plotted against bound 125I-FGF2, where
tection system (Amersham). specific binding (moles/well) was total binding minus nonspecific
FGFR1: Crude membrane fractions of control PC12 cells and DN- binding, and free 125I-FGF2 (expressed in molar terms) was deter-
FGFR expressing clone 2 were loaded onto a 7.5% polyacrylamide mined by subtracting total 125I-FGF2 bound from 125I-FGF2 added per
gel (100 mg/well) and proteins resolved by SDS–PAGE before being well. The dissociation is taken as 1/slope, and the x-axis intersection
transferred to nitrocellulose replicas. These were blocked overnight indicates the number of moles of 125I-FGF2 bound per well, from
at 48C with 5% nonfat dried milk in PBS/0.02% Tween20, incubated which the number of 125I-FGF2 binding sites per cell can be deter-
for 4 hr at room temperature with 5 mg/ml anti-FGFR1 mAb (UBI) in mined.
PBS/0.2% Tween, and then sequentially with biotinylated antimouse
immunoglobulin and peroxidase-conjugated streptavidin, both di-
Cross-Linking of 125I-FGF2 to Cerebellar Neurons
luted 1:3000 (Amersham). After washing, immunoreactive bands
Cerebellar neurons from PND2 wild-type and DN-FGFR–expressing
were visualized using an ECL detection system (Amersham).
mice were plated onto poly-lysine–coated 6 cm tissue culture plates
Tyrosine-phosphorylated Trk: Nitrocellulose replicas of Trk anti-
in SATO medium containing 2% FCS. After 20 hr, the cells were
body-precipitated proteins resolved by SDS–PAGE (see below) were
washed twice with binding buffer (PBS/0.1%BSA/0.1mM DTT) and
blocked overnight at 48C with 2% nonfat dried milk in PBS/0.2%
incubated for 2 hr on ice in 2 mls of binding buffer containing 10
Tween 20 and then sequentially incubated for 1 hr each with anti-
ng/ml 125I-FGF2 and 5 mg/ml heparin. Cells were then washed twice
phosphotyrosine antibody 4G10 (UBI), diluted 1:2000, and HRP-
and incubated on ice in 2 mls PBS containing 1 mM BS3 cross-
conjugated antimouse immunoglobulin (Vector), diluted 1:3000.
linker (Pierce). After 30 min, the cross-linking reaction was stopped
by adding 0.2 mls of 103 stop buffer (final concentration 50 mM
Tris-Cl (pH7.4), 0.2M glycine, 2 mM EDTA, 1 mg/ml aprotinin, 1 mg/Immunoprecipitation of Tyrosine-Phosphorylated Proteins
ml leupeptin, and 1 mM PMSF), and incubated on ice for a furtherControl PC12 cells or PC12 cells expressing DN-FGFR (clone 2)
30 min. The mixture was decanted and cells scraped into 1 ml PBSwere each plated onto four 6 cm poly-lysine–coated tissue culture
containing 1 mg/ml aprotinin, 1 mg/ml leupeptin, and 1mM PMSFplates at a density of 5 3 106 cells/plate, and cultured overnight in
before being collected by centrifugation. Cell pellets were solubi-SATO medium containing 2% FCS. After a 4 hr incubation in 2 ml
lized in 100 ml 23 SDS-containing sample buffer, boiled for 5 min,serum-free DMEM, cells were treated for 10 min with 100 ng/ml
sonicated, and resolved by SDS–PAGE. The gel was then dried andFGF2, 10 mg/ml NCAM-Fc, 10 mg/ml L1-Fc (both 3Ig domain ver-
125I-FGF2–bound complexes visualised using a Molecular Dynamicssions), or left in serum-free DMEM (control). Cells were washed once
phosphorimager.with ice-cold PBS and scraped into 200 ml modified RIPA buffer (50
mM Tris (pH 7.4), 1% NP40, 0.25% deoxycholate, 150 mM NaCl, 1
Preparation of CAM-Fc ChimerasmM EGTA, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mM
Chimeric molecules consisting of the Fc region of human IgG (hingeNa3VO4, 1 mM NaF). After incubation on ice for 45 min, lysates were
CH2-CH3) and the entire extracellular domains of human NCAM orcentrifuged to remove nuclei and insoluble material, and protein
human L1, or the first three Ig domains from each CAM, were createdconcentration assessed using a Pierce protein assay kit. Lysates
by inserting coding sequences derived from human NCAM cDNA(200 ml, adjusted to 1 mg/ml) were rotated overnight at 48C in the
(Gower et al., 1988) or human L1 cDNA (Reid and Hemperly, 1991)presence of 20 ml 4G10-agarose slurry (4G10 antiphosphotyrosine
into the pIg vector (Fawcett et al., 1992) using a standard cloningantibody coupled to agarose, UBI). Agarose beads were washed
strategy (Doherty et al., 1995). Soluble NCAM-Fc and L1-Fc chime-three times with modified RIPA buffer and boiled in 70 ml 23 SDS
ras were harvested from the culture medium of COS-7 cells tran-sample buffer for 5 min to release immunoprecipitated proteins,
siently transfected with plasmid DNA, and purified by binding towhich were resolved by SDS–PAGE, transferred to nitrocellulose,
protein A sepharose beads.and immunoprobed with anti-FGFR1 mAb (UBI) as described. Immu-
noprecipitation of Trk receptors was carried out as above except
that cell lysates were incubated at 48C with 1 mg anti-Trk polyclonal Preparation of L1-Fc–Coated Substrata
The use of the L1-Fc chimera in neurite outgrowth assays has beenantibody (Santa Cruz) for 1 hr and then overnight in the presence
of Protein A sepharose beads. Washed beads were then boiled in described in detail previously (Doherty et al., 1995; Williams et al.,
1995b). Briefly, eight-chamber tissue culture slides were coated with23 SDS sample buffer and immunoprecipitated proteins resolved
by SDS–PAGE as above. Nitrocellulose replicas were immuno- poly-lysine, followed by 10 mg/ml goat antihuman IgG (Fc-specific)
in DMEM for 1 hr. The wells were then treated with DMEM/10%probed with antiphosphotyrosine antibody 4G10 (UBI).
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FCS to block nonspecific protein-binding sites, followed by a 2-hr J., Nerenberg, M., and Sutcliffe, J.G. (1990). Transgenic mice ex-
pressing (-galactosidase in mature neurons under neuron-specificincubation with 200 ml of DMEM containing 2% FCS and the full-
length L1-Fc at 200 ng/ml. All incubations were at 378C in a tissue enolase promoter control. Neuron 5, 187–197.
culture incubator. Under these conditions, the chimera only binds Ginsberg, M.H., Du, X., and Plow, E.F. (1992). Inside-out integrin
to the wells coated with antihuman Fc antibody and as such it is signaling. Curr. Opin. Cell Biol. 4, 766–771.
affinity captured in an orientation-specific manner.
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